Clocks spring forward and an hour of sleep is lost while an extra hour of sunlight is gained. The week when Daylight Savings Time goes into effect has been known as Sleep Awareness Week, or Sleep ...

Participants were observed for two seasons, from August 31, 2021, to December 18, 2023, to evaluate vaccine efficacy, its safety and the increase in antibody levels against RSV-A and RSV-B variants.

GRAND RAPIDS, Mich. — As respiratory syncytial virus (RSV) cases surge, one family's harrowing experience highlights the importance of prevention. Emily and Joey Spadafore watched helplessly as ...

1 Day SGIOY -2.62% DJIA 1.39% S&P 500 1.59% Health Care/Life Sciences -0.37% ...

Among the viruses circulating most are COVID-19, flu and RSV. So far this season, the CDC estimates, there have been at least 24 million flu illnesses, 310,000 hospitalizations and 13,000 deaths ...

A recent phase 2, randomized, placebo-controlled, double-blind human challenge study conducted in a joint endeavor by Shionogi and UBE Corporation demonstrated the efficacy and safety of a novel ...

Photo shows New Year's Weather: Dark grey storm clouds over a green forested area, with a rain storm on the horizon.

Respiratory syncytial virus (RSV) is a cold-like illness that can be dangerous for infants, especially those born during the respiratory season. We finally have a tool to protect them, yet ...

Pediatric RSV treatment itself is expected to be a multi-billion-dollar ... oseltamivir (Tamiflu®, Roche), peramivir (Rapivab®, Biocryst), and baloxavir (Xofluza®, Shionogi/Roche). Additionally, ...

Pediatric RSV treatment itself is expected to be a multi ... peramivir (Rapivab®, Biocryst), and baloxavir (Xofluza®, Shionogi/Roche). Additionally, NV-387 also demonstrated activity against ...

Pediatric RSV treatment itself is expected to be a multi ... peramivir (Rapivab®, Biocryst), and baloxavir (Xofluza®, Shionogi/Roche). Additionally, NV-387 also demonstrated activity against ...